1. Minocycline Administration Does Not Have an Effect on Retinal Ganglion Cell Survival in a Murine Model of Ocular Hypertension.
- Author
-
Sánchez-Migallón MDC, Di Pierdomenico J, Gallego-Ortega A, García-Ayuso D, Vidal-Sanz M, Agudo-Barriuso M, and Valiente-Soriano FJ
- Subjects
- Animals, Mice, Caspase 3 metabolism, Apoptosis drug effects, Microglia drug effects, Microglia metabolism, Mice, Inbred C57BL, Retinal Ganglion Cells drug effects, Retinal Ganglion Cells pathology, Retinal Ganglion Cells metabolism, Minocycline pharmacology, Minocycline therapeutic use, Minocycline administration & dosage, Ocular Hypertension drug therapy, Ocular Hypertension pathology, Disease Models, Animal, Cell Survival drug effects
- Abstract
This study aims to investigate two key aspects in a mouse model of ocular hypertension (OHT): first, the time course of retinal ganglion cell (RGC) death and the parallel activation of caspase-3 (a-Casp3+ cells) to narrow the therapeutic window; and second, the effect of caspase-3 and microglia inhibition by minocycline on RGC rescue in this model. RGC loss after OHT induction was significant at day 7 and progressed to 30 days. However, anatomical RGC death was preceded by significant Casp3 activation on day 3. Microglial inhibition by minocycline did not alter the course of OHT or rescue RGCs but resulted in a decrease in a-Casp3+ cells and phagocytic and total microglia. Therefore, RGC death commitment occurs earlier than their loss of Brn3a expression, microglial cells do not exacerbate RGC loss, and while this death is primarily apoptotic, apoptosis inhibition does not rescue RGCs, suggesting that alternative death pathways play a role in glaucomatous injury.
- Published
- 2024
- Full Text
- View/download PDF